Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-06-06

Clinical Trial Update: Intralesional Steroids in the Treatment of Alopecia Areata [Phase 4]

View source ↗

Summary

Phase 4 trial on intralesional steroids for alopecia areata was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Columbia University | Conditions: Alopecia Areata | Phase 4 | Status: TERMINATED | Results posted: 2019-06-06